Carl-Johan Gustafson
Algemeen Directeur bij NATTARO LABS AB
Profiel
Carl-Johan Gustafson is currently the Chief Executive Officer at Nattaro Labs AB and the Director at MVIC AB.
He is a graduate of the University of Lund and has an undergraduate degree from ESCP Europe Campus Paris.
Actieve functies van Carl-Johan Gustafson
| Bedrijven | Functie | Begin |
|---|---|---|
| NATTARO LABS AB | Algemeen Directeur | 01-01-2015 |
MVIC AB
 MVIC AB Miscellaneous Commercial ServicesCommercial Services MVIC AB is an inhalation CRO and partner with over 70 project managers and specialists in discovery, formulation, regulatory, device, and product development. MVIC is based in Stockholm, SE, and has GMP facilities, well-equipped labs, advanced instrumentation, and highly skilled staff. The Swedish company has extensive experience in inhalation product testing and characterization, with standardized procedures or customized to customer requirements. The private company is a team of 70 inhalation experts, 27 with a PhD, covering areas from discovery up to late-phase development. | Directeur/Bestuurslid | 01-01-2019 |
Opleiding van Carl-Johan Gustafson
| University of Lund | Graduate Degree |
| ESCP Europe Campus Paris | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NATTARO LABS AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
MVIC AB
MVIC AB Miscellaneous Commercial ServicesCommercial Services MVIC AB is an inhalation CRO and partner with over 70 project managers and specialists in discovery, formulation, regulatory, device, and product development. MVIC is based in Stockholm, SE, and has GMP facilities, well-equipped labs, advanced instrumentation, and highly skilled staff. The Swedish company has extensive experience in inhalation product testing and characterization, with standardized procedures or customized to customer requirements. The private company is a team of 70 inhalation experts, 27 with a PhD, covering areas from discovery up to late-phase development. | Commercial Services |
